StandardStandard

Advanced‐stage cancer and time to diagnosis: An International Cancer Benchmarking Partnership (ICBP) cross‐sectional study. / Tørring, M L; Falborg, Alina Zalounina; Jensen, H. et al.
Yn: European Journal of Cancer Care, Cyfrol 28, Rhif 5, e13100, 09.2019.

Allbwn ymchwil: Cyfraniad at gyfnodolynErthygladolygiad gan gymheiriaid

HarvardHarvard

Tørring, ML, Falborg, AZ, Jensen, H, Neal, RD, Weller, D, Reguilon, I, Law, B, Vedsted, P & Menon, U 2019, 'Advanced‐stage cancer and time to diagnosis: An International Cancer Benchmarking Partnership (ICBP) cross‐sectional study', European Journal of Cancer Care, cyfrol. 28, rhif 5, e13100. https://doi.org/10.1111/ecc.13100

APA

Tørring, M. L., Falborg, A. Z., Jensen, H., Neal, R. D., Weller, D., Reguilon, I., Law, B., Vedsted, P., & Menon, U. (2019). Advanced‐stage cancer and time to diagnosis: An International Cancer Benchmarking Partnership (ICBP) cross‐sectional study. European Journal of Cancer Care, 28(5), Erthygl e13100. https://doi.org/10.1111/ecc.13100

CBE

Tørring ML, Falborg AZ, Jensen H, Neal RD, Weller D, Reguilon I, Law B, Vedsted P, Menon U. 2019. Advanced‐stage cancer and time to diagnosis: An International Cancer Benchmarking Partnership (ICBP) cross‐sectional study. European Journal of Cancer Care. 28(5):Article e13100. https://doi.org/10.1111/ecc.13100

MLA

VancouverVancouver

Tørring ML, Falborg AZ, Jensen H, Neal RD, Weller D, Reguilon I et al. Advanced‐stage cancer and time to diagnosis: An International Cancer Benchmarking Partnership (ICBP) cross‐sectional study. European Journal of Cancer Care. 2019 Medi;28(5):e13100. Epub 2019 Mai 22. doi: 10.1111/ecc.13100

Author

Tørring, M L ; Falborg, Alina Zalounina ; Jensen, H. et al. / Advanced‐stage cancer and time to diagnosis: An International Cancer Benchmarking Partnership (ICBP) cross‐sectional study. Yn: European Journal of Cancer Care. 2019 ; Cyfrol 28, Rhif 5.

RIS

TY - JOUR

T1 - Advanced‐stage cancer and time to diagnosis: An International Cancer Benchmarking Partnership (ICBP) cross‐sectional study

AU - Tørring, M L

AU - Falborg, Alina Zalounina

AU - Jensen, H.

AU - Neal, R.D.

AU - Weller, David

AU - Reguilon, Irene

AU - Law, Becki

AU - Vedsted, Peter

AU - Menon, Ushu

PY - 2019/9

Y1 - 2019/9

N2 - ObjectiveTo investigate the relationship between tumour stage at diagnosis and selected components of primary and secondary care in the diagnostic interval for breast, colorectal, lung and ovarian cancers.MethodsObservational study based on data from 6,162 newly diagnosed symptomatic cancer patients from Module 4 of the International Cancer Benchmarking Partnership. We analysed the odds of advanced stage of cancer as a flexible function of the length of primary care interval (days from first presentation to referral) and secondary care interval (days from referral to diagnosis), respectively, using logistic regression with restricted cubic splines.ResultsThe association between time intervals and stage was similar for each type of cancer. A statistically significant U‐shaped association was seen between the secondary care interval and the diagnosis of advanced rather than localised cancer, odds decreasing from the first day onwards and increasing around three and a half months. A different pattern was seen for the primary care interval, flat trends for colorectal and lung cancers and a slightly curved association for ovarian cancer, although not statistically significant.ConclusionThe results confirm previous findings that some cancers may progress even within the relatively short time frame of regulated diagnostic intervals. The study supports the current emphasis on expediting symptomatic diagnosis of cancer.

AB - ObjectiveTo investigate the relationship between tumour stage at diagnosis and selected components of primary and secondary care in the diagnostic interval for breast, colorectal, lung and ovarian cancers.MethodsObservational study based on data from 6,162 newly diagnosed symptomatic cancer patients from Module 4 of the International Cancer Benchmarking Partnership. We analysed the odds of advanced stage of cancer as a flexible function of the length of primary care interval (days from first presentation to referral) and secondary care interval (days from referral to diagnosis), respectively, using logistic regression with restricted cubic splines.ResultsThe association between time intervals and stage was similar for each type of cancer. A statistically significant U‐shaped association was seen between the secondary care interval and the diagnosis of advanced rather than localised cancer, odds decreasing from the first day onwards and increasing around three and a half months. A different pattern was seen for the primary care interval, flat trends for colorectal and lung cancers and a slightly curved association for ovarian cancer, although not statistically significant.ConclusionThe results confirm previous findings that some cancers may progress even within the relatively short time frame of regulated diagnostic intervals. The study supports the current emphasis on expediting symptomatic diagnosis of cancer.

U2 - 10.1111/ecc.13100

DO - 10.1111/ecc.13100

M3 - Article

VL - 28

JO - European Journal of Cancer Care

JF - European Journal of Cancer Care

SN - 0961-5423

IS - 5

M1 - e13100

ER -